De-escalation towards omission is the tipping point of individualizing breast cancer surgery

Tailoring of breast cancer treatment to the individual has especially occurred in breast cancer surgery: paradigms have changed from Halsted's radical mastectomy in 1882, to simple mastectomy, to lumpectomy. Within the next decade, we might face another paradigm change of omitting breast cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heil, Jörg (VerfasserIn) , Pfob, André (VerfasserIn) , Kuerer, Henry Mark (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 March 2020
In: European journal of surgical oncology
Year: 2020, Jahrgang: 46, Heft: 8, Pages: 1543-1545
ISSN:1532-2157
DOI:10.1016/j.ejso.2020.03.208
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejso.2020.03.208
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0748798320303553
Volltext
Verfasserangaben:Joerg Heil, André Pfob, Henry Mark Kuerer
Beschreibung
Zusammenfassung:Tailoring of breast cancer treatment to the individual has especially occurred in breast cancer surgery: paradigms have changed from Halsted's radical mastectomy in 1882, to simple mastectomy, to lumpectomy. Within the next decade, we might face another paradigm change of omitting breast cancer surgery at all in case of a complete response after neoadjuvant systemic treatment. In this article, we provide an overview of the reasoning for this new paradigm change, the criticism it has evoked, and under which conditions it might be incorporated into clinical practice. We also take a look at previous paradigm changes in breast cancer surgery and the insights they provide us in the current situation on a statistical but also on a psychological level.
Beschreibung:Gesehen am 07.10.2020
Beschreibung:Online Resource
ISSN:1532-2157
DOI:10.1016/j.ejso.2020.03.208